WEST PHARMACEUTICAL SERVICES INC (WST) Options Risk Score
Real-time risk analysis for WST options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full WST options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan WST Now — Free →
Is it risky to sell options on WEST PHARMACEUTICAL SERVICES INC (WST) right now?
For a 4-week expiry, WEST PHARMACEUTICAL SERVICES INC (WST) carries an options catalyst-risk score of 86 out of 100 (HIGH). That score is driven by 11 recent news items, 2 active legal filings and 84 clinical-trial catalysts falling inside the 4-week window. A HIGH reading (70+) means WST has a dated event inside the window, so an option sold here carries gap risk that time decay alone will not pay for. The score ranks event exposure, not the likely direction of the move.
WST shows an IV Rank of 81 — implied volatility is near the top of its own one-year range, so WST options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 47%. IV Rank answers how WST options are priced against their own history, which is the starting point for choosing between selling and buying premium.
The next WST report is not until 2026-07-23, beyond the near-term window.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer